• Journal of Oral Medicine and Pain
• /
• v.32 no.3
• /
• pp.273-281
• /
• 2007

Zinc compounds have been used in various fields - cosmetics, medicine, and dentistry -because of its effective functions to human tissues or organs. Especially, it is well known that zinc has many biologic effects in oral cavity. Zinc ion can affect various oral microorganisms, resulting in reduction of oral bacteria, dental plaque, and dental caries. Also, zinc ion has an ability to reduce amounts of oral anaerobic bacteria and oral VSC and can reduce oral malodor. The author summarized the characteristics and toxicity of zinc, several forms of zinc compounds applied in human tissues, and reviewed biologic effects of Zinc in oral cavity (anti-bacterial effects, anti-plaque effects, anti-caries effects, and anti-VSC effects of zinc). Because of many advantages of zinc in oral cavity, it can be concluded that application of zinc compound to various oral diseases will be extended and activated, and promising.

• Microbiology and Biotechnology Letters
• /
• v.32 no.2
• /
• pp.172-178
• /
• 2004

This research is performed for a biological control of Chinese cabbage clubroot, we isolated an antagonistic bacterium AC-3 against Plasmodiophora sp., causal pathogens of cabbage clubroot. The isolated strain was identified as Streptomyces sp. by culture morphology, biochemical reactions, and homology research based on l6S rDNA sequences. Streptomyces sp. AC-3 produced chitinase (9.3 units/$m\ell$) in culture broth. So Plasmodiophora sp. mycelia changed abnonnal swelling, curling and branching mycelia by Streptomyces sp. AC-3 culture. In a field infected by Plasmodiophora sp., the treatment of a organic fertilizer added 2% Streptomyces sp. AC-3 microbial inoculant, it resulted in about 50% reducing the severity of cabbage clubroot significantly on cabbage plants compared with treated organic fertilizer plants. Additional disease such as sclerotinia rot, fusarium wilt and pythium rot were also significantly reduced by the treatment of the organic fertilizer added Streptomyces sp. AC-3 microbial inoculant.

• Proceedings of the Korean Society of Applied Pharmacology
• /
• 1994.04a
• /
• pp.346-346
• /
• 1994

1. 위장관통과 실험결과 polycarbphil 흑은 carbomer로 코팅한 생체막점착성 마이크로캅셀 모두가 Eudragit RS/RL 마이크로캅셀보다 위 및 소장상부에 다량 존재하는 것으로 보아 Polymer의 생체막점착성에 의해 제제의 위내용배출이 억제되었음을 알 수 있었다. 2. Polycarbophil 흑은 carbomer로 코팅한 생체점착성 마이크로캅셀의 AUC는 Eudragit RS/RL 마이크로캅셀의 결과에 비해 현저히 증가되었다. Polycarbophil로 코팅한 생체막점착성 마이크로캅셀은 carbomer로 코팅한 제제에 비해 Cm의 증가뿐아니라 전체적인 약물흡수의 증가와 높은 혈중농도의 지속을 보여주어 생체막점착성 제제의 이상적인 약물흡수패턴을 보여주었다. 3. 흡수속도효율 (ARE)면에서 생체막점착성 마이크로캅셀이 코팅전의 마이크로캅셀에 비해 약간 떨어졌으나, polycarbophil 코팅제제의 경우 전체적인 흡수양상이 마이크로캅셀에 비해 우수하고 또한 제어방출효율 (CRE)이 현저하게 증가되어 생체막점착성 제제로서의 유용성을 확인할 수 있었다. 4. 위내용배출의 지연효과, AUC, CRE 등을 종합해 볼때, Polycarbophil 로 코팅한 생체막점착성 마이크로캅셀은 투여횟수의 감소 및 생체이용율을 향상시키는 유용한 제제로 평가되었다.

• Korean Journal of Soil Science and Fertilizer
• /
• v.45 no.2
• /
• pp.162-168
• /
• 2012

An nematophagous fungi Arthrobotrys thaumasia Nema-1 and Bacillus subtilis C-9, which degrade the collagen and gelatin, were isolated from horticulture plantation soil in Kyungpook Sungju-gun Seonnam-myun and Chungnam Gongju-gun Woosung-myun to develop biological nematode pesticide. When $5,000mg\;kg^{-1}$ of A. thaumasia Nema-1 nematicide powder ($7.0{\times}10^3cfu\;g^{-1}$) was treated to pot including Meloidogyne incognita, the number of nematode's egg mass, which is a index of nematicidal activity, decreased to 35% compared to control. While the number of nematode's egg mass decreased to 67% by treating the nematicide powder mixture of $5,000mg\;kg^{-1}$ Nema-1 and B. subtilis C-9 ($8.5{\times}10^5cfu\;g^{-1}$). Furthermore the number of nematode's egg mass of the mixture containing cinnamon extract $10mg\;kg^{-1}$, each $5,000mg\;kg^{-1}$ of Nema-1 and C-9 nematicide powder was decreased to 84%, comparing to the result showed the number of nematode's egg mass decreased to 24%, by the treatment of chemical nemato pesticide Fosthiazate $24mg\;kg^{-1}$. These results suggested the mixture of microorganisms and plant extract was more effective biological nematicide than the case of only microorganism or plant extract for nematode control.

• Journal of Life Science
• /
• v.21 no.4
• /
• pp.554-560
• /
• 2011

This study was performed to investigate the effects of microbial augmentation on the biological treatment of paper mill wastewater. Three bacteria (KN11, KN13, KN27) capable of degrading aromatic compounds and a bacterial strain (GT21) producing an extracellular cellulase were isolated from soil and wastewater by selective enrichment culture. Through morphological, physiological, and biochemical taxonomies, isolated strains of KN11, KN13, KN27, and GT21 were identified as Acinetobacter sp., Neisseria sp., Bacillus sp., and Pseudomonas sp. and named Acinetobacter sp. KN11, Neisseria sp. KN13, Bacillus sp. KN27, and Pseudomonas sp. GT21, respectively. For analysis of non-biodegradable and chemical oxygen demand (COD)-increasing matter in a paper mill wastewater, we utilized GC/MS to detect aromatic compounds and their derivatives containing several substituted functional groups. The microbial augmentation, J30 formulated with the mixture of bacteria including Acinetobacter sp. KN11, Neisseria sp. KN13, Bacillus sp. KN27, and Pseudomonas sp. GT21, was used for the treatment of paper mill wastewater. The optimum temperature and pH for COD removal of the microbial augmentation, J30, were $30^{\circ}C$ and 7.5, respectively. For evaluation of the industrial applicability of the microbial augmentation, J30 in the pilot test, treatment efficiency was examined using paper mill wastewater. The microbial augmentation, J30, showed a COD removal rate of 87%. On the basis of the above results, we designed the wastewater treatment process of the activated sludge system.

• Korean Journal of Clinical Pharmacy
• /
• v.18 no.2
• /
• pp.132-136
• /
• 2008

생물학적동등성시험기준에 따라 플레록사신정 (Fleroxacin, 100 mg) 을 시험약으로 하고 메가로신정 100 mg을 대조약으로 하여 $2{\times}2$ 교차 시험법에 따라 건강한 성인 지원자 24명에게 3정 (fleroxacine, 300 mg/정) 씩을 경구투여한 후, 각 피험자들의 혈중 약물농도 데이터로부터 구한 혈중농도-시간곡선하면적 (AUCtmax.) 과 최고혈중농도 (Cmax) 등의 생체이용률 파라미터에 대해 통계학적으로 고찰하여 두 제제간의 생물학적동등성을 평가하였다. 혈중 약물농도는 HPLC/UV 검출기로 분석하다. 플레록사신정의 대조약과 시험약에 대한 동등성 여부를 종합적으로 판단하여 보면 생물학적동등성시험의 판단 기준인 2항목 (AUCt, Cmax) 에 대하여 두 가지 비교항목 중 AUCt 값의 경우 대조약은 $44.26{\pm}7.12{\mu}g{\cdot}hr/mL$, 시험약은 $4.11{\pm}1.63{\mu}g/mL$이며 두 약물의 로그변환한 평균치 차의 90% 신뢰구간은 log 0.9570 에서 log 1.0565 이다. Cmax 값의 경우 대조약은 $45.16{\pm}10.04{\mu}g{\cdot}hr/mL$, 시험약은 $3.78{\pm}1.01{\mu}g/mL$ 이며, 대조약과 시험약의 로그변환한 평균치 차의 90% 신뢰구간이 log 0.8369에서 log 1.0626 로서, AUCt 와 Cmax 두 항목 모두 log 0.8에서 log 1.25 이내이어야 한다는 생물학적동등성시험 기준을 충족시켰다. 이러한 결과들로부터, 시험약 플레록사신정 (Fleroxacin, 100mg)은 대조약인 메가로신정 100 mg 대하여 생물학적동등성의 판단 기준인 두 항목 AUCt와 Cmax에 있어서 생물학적으로 동등함을 알 수 있었다.

• Journal of Veterinary Clinics
• /
• v.29 no.3
• /
• pp.233-236
• /
• 2012

Cefquinome, a fourth generation cephalosporin, has been solely used for veterinary medicine and has a broad antibacterial spectrum against gram-negatives and gram-positives being very stable to ${\beta}$-lactamases. This study was conducted to evaluate the bioequivalence of two cefquinome 2.5% products in piglets. Plasma cefquinome concentrations were analyzed by liquid chromatography-mass spectrometry (LC/MS). Mean maximum concentration ($C_{max}$) of test product ($Cequus^{(R)}$) and reference product ($Cobactan^{(R)}$) were $4.34{\pm}0.58$ and $4.22{\pm}0.47{\mu}g/mL$, and mean area under the concentration time curve ($AUC_{0{\rightarrow}{\infty}}$) values were $10.43{\pm}1.96$ and $10.25{\pm}2.98{\mu}g{\cdot}h/mL$, respectively. The 90% confidence intervals for the ratio of $C_{max}$ (0.941-1.115), and $AUC_{0{\rightarrow}{\infty}}$ (0.927-1.172) values for the test and reference products were within the acceptable bioequivalence limit of 0.80-1.25. It is concluded that two commercial cefquinome injectable solutions are bioequivalent in their extent of drug absorption in piglets.

• 한국임상약학회:학술대회논문집
• /
• 2007.12a
• /
• pp.170-170
• /
• 2007

• 동물약계
• /
• no.47
• /
• pp.4-4
• /
• 1998

[ $\cdot$ ]동물약사감시 행정처분 결과 홍보 $\cdot$98년도 동물약품 제조용 유당 배정 현황 $\cdot$생물학적제제 밀봉용 알루미늄캡 가격 인상 $\cdot$`98년도 검정신청 예정량 조사 $\cdot$제10차 수출촉진협의회 개최 $\cdot$98년도 상반기 알찬거래선 선정 $\cdot$98년도 유당 알선업체 선정 $\cdot$동물용의약품 결재조건 개선

• 동물약계
• /
• no.5
• /
• pp.3-3
• /
• 1993

1. 제조업 허가사항 변경 2. 국가검정 동물용의약품 국가검정 면제 3. KGMP 추진현황조사(93. 9. 2.) 4. 설명회 개최안내(93. 9. 8) 5. 의정활동 자료협조(93. 9. 16.) 6. 국가검정 동물의약품 관리 철저 요청(93. 9. 17.) 7. $\ulcorner$산업 및 품목분류표$\lrcorner$ 개선의견 제출(93. 9. 16.) 8. 생물학적제제 특별 관리 방안 중간 추진현황